XML 36 R26.htm IDEA: XBRL DOCUMENT v3.24.0.1
Note 12 - Stock-based Compensation (Tables)
9 Months Ended
Dec. 31, 2023
Notes Tables  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
  

Nine-Month Periods Ended

 
  

December 31, 2023

  

January 1, 2023

 
  

Weighted-

      

Weighted-

     
  

Average

  

Number of

  

Average

  

Number of

 
  

Exercise

  

Options

  

Exercise

  

Options

 
  

Price

  

Outstanding

  

Price

  

Outstanding

 

Outstanding at Beginning of Period

 $7.32   735,500  $7.39   635,500 

Granted

  5.18   130,000   6.54   120,000 

Exercised

  -   -   4.92   (20,000)

Expired

  6.14   (10,000)  -   - 

Outstanding at End of Period

  7.01   855,500   7.32   735,500 

Exercisable at End of Period

  7.41   665,500   7.42   499,000 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

Nine-Month Periods Ended

 
  

December 31, 2023

  

January 1, 2023

 

Number of options issued

  10,000   120,000   120,000 

Grant date

 

November 14, 2023

  

June 21, 2023

  

June 7, 2022

 

Dividend yield

  7.60%  6.08%  4.89%

Expected volatility

  20.00%  25.00%  30.00%

Risk free interest rate

  4.56%  4.29%  2.95%

Contractual term (years)

  10.00   10.00   10.00 

Expected term (years)

  3.00   3.00   4.00 

Forfeiture rate

  5.00%  5.00%  5.00%

Exercise price (grant-date closing price) per option

 $4.21  $5.26  $6.54 

Fair value per option

 $0.20  $0.46  $0.90 
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
  

Three-Month Period Ended December 31, 2023

  

Three-Month Period Ended January 1, 2023

 
  

Cost of

  

Marketing &

      

Cost of

  

Marketing &

     
  

Products

  

Administrative

  

Total

  

Products

  

Administrative

  

Total

 

Options Granted in Fiscal Year

 

Sold

  

Expenses

  

Expense

  

Sold

  

Expenses

  

Expense

 

2021

 $-  $-  $-  $-  $11  $11 

2022

  -   -   -   9   20   29 

2023

  5   7   12   6   7   13 

2024

  3   4   7   -   -   - 
                         

Total stock option compensation

 $8  $11  $19  $15  $38  $53 
  

Nine-Month Period Ended December 31, 2023

  

Nine-Month Period Ended January 1, 2023

 
  

Cost of

  

Marketing &

      

Cost of

  

Marketing &

     
  

Products

  

Administrative

  

Total

  

Products

  

Administrative

  

Total

 

Options Granted in Fiscal Year

 

Sold

  

Expenses

  

Expense

  

Sold

  

Expenses

  

Expense

 

2021

 $-  $-  $-  $3  $37  $40 

2022

  10   21   31   31   66   97 

2023

  17   24   41   12   17   29 

2024

  6   8   14   -   -   - 
                         

Total stock option compensation

 $33  $53  $86  $46  $120  $166 
  

Three-Month Periods Ended

  

Nine-Month Periods Ended

 

Stock Granted in Fiscal Year

 

December 31, 2023

  

January 1, 2023

  

December 31, 2023

  

January 1, 2023

 

2021

 $-  $9  $-  $76 

2022

  37   113   147   472 

2023

  23   78   160   130 

2024

  111   -   180   - 
                 

Total stock grant compensation

 $171  $200  $487  $678 
Schedule of Nonvested Share Activity [Table Text Block]

Number of Shares

  

Fair Value per Share

 

Grant Date

 

Vesting Period (Years)

60,412   $4.85 

August 15, 2023

 

One

46,896   6.65 

August 16, 2022

 

One

40,165   7.47 

August 11, 2021

 

One

41,452   5.79 

August 12, 2020

 

Two

Number of Shares

  

Fair Value per Share

 

Grant Date

 

Vesting Date

26,000   $4.77 

August 14, 2023

 

August 14, 2024

40,000   5.85 

March 21, 2023

 

March 21, 2025

25,000   7.98 

June 9, 2021

 

June 9, 2022

10,000   7.60 

February 22, 2021

 

February 22, 2023

20,000   4.92 

June 10, 2020

 

June 10, 2022